Skip to main content
ISTH 2024 Main banner
Back

Robert Flaumenhaft, MD, PhD

Professor
BIDMC/Harvard Medical School
Boston, Massachusetts, United States

Robert Flaumenhaft, MD, PhD is Chief of the Division of Hemostasis and Thrombosis at BIDMC and Professor of Medicine at Harvard Medical School. Dr. Flaumenhaft received his M.D. and Ph.D. from New York University School of Medicine, completed a fellowship in Hematology/Oncology at BIDMC, and received a M.M.Sc. from Harvard Medical School. He performed his PhD research with Dr. Daniel Rifkin and his post-doctoral work with Drs. Bruce and Barbara Furie. His laboratory focuses on platelet and endothelial cell biology and mechanisms of thrombus formation. His laboratory has made seminal contributions studying mechanisms of platelet granule secretion, the role protein disulfide isomerase (PDI) and other thiol isomerases in thrombus formation, and in vivo thrombosis in the setting of systemic inflammation. Dr. Flaumenhaft has or has had editorial positions at Blood, JCI Insight, Thrombosis and Haemostasis, Thrombosis Research, and Seminars in Thrombosis and Hemostasis. He chaired the Hemostasis, Thrombosis, Blood Cells, and Transfusion study section, was the scientific co-chair of the ASH 2019 meeting, and was the Chairman of the FASEB meeting on Functional Disulfide Bonds in Health and Disease. His work in platelet biology and thrombotic mechanisms has earned him awards from the Howard Hughes Medical Foundation, the Burroughs Wellcome Fund, the American Society of Hematology, and the American Heart Association. He was elected to the American Society for Clinical Investigation and subsequently to the American Association of Physicians. He is the recipient of an Outstanding Investigator Award from NIH. In additional to his academic pursuits, Dr. Flaumenhaft is the founder of PlateletDiagnostics, a device company that specializes in the development of platelet function tests. He has a special interest in mentoring physician-scientists and PhDs, having trained over 40 post-docs in the field of Hemostasis and Thrombosis, and is director of the T32 training program, “Blood Coagulation and Vascular Biology”.

Presentation(s):